European Exposure Study
NCT01237912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1667
Last updated 2019-11-07
Summary
The current study was designed to determine the exposure of adult smokers and non-smokers to cigarette smoke constituents through evaluation of selected biomarkers of exposure.
Conditions
- Smoking
Sponsors & Collaborators
-
Philip Morris Products S.A.
lead INDUSTRY
Principal Investigators
-
Stephen Smith · Celerion, 22-24 Lisburn Road, Belfast, BT9 6AD, Northern Ireland
Eligibility
- Min Age
- 21 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2006-05-31
- Completion
- 2006-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Exploratory THS 2.1 Biomarkers of Exposure Study
NCT01780714 ·Status: COMPLETED ·Phase: NA
-
Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges
NCT03432312 ·Status: COMPLETED ·Phase: PHASE1
-
CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products
NCT03153761 ·Status: COMPLETED ·Phase: NA
-
Nicotine Pharmacokinetic Study of Heated Tobacco and Heated Herbal Products
NCT06093659 ·Status: COMPLETED ·Phase: NA
-
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
NCT00371813 ·Status: COMPLETED ·Phase: PHASE3
-
A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation
NCT00143286 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
NCT00717093 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
NCT03559751 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
NCT01244061 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
NCT03692078 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking
NCT00635401 ·Status: COMPLETED ·Phase: PHASE2
-
Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence
NCT05487456 ·Status: COMPLETED ·Phase: NA
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette
NCT02511704 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Pharmacokinetics of THS Single Use of a Regular or a Menthol Stick Compared to CIG
NCT05789420 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
NCT05707871 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
NCT01370356 ·Status: COMPLETED ·Phase: PHASE4
-
A Dietary Supplement for Early Cigarette Withdrawal
NCT02042521 ·Status: COMPLETED ·Phase: PHASE2
-
Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
NCT02538042 ·Status: COMPLETED ·Phase: NA
-
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
NCT06456671 ·Status: COMPLETED ·Phase: NA
-
Little Cigar Oxidants
NCT06310187 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
NCT01262170 ·Status: COMPLETED ·Phase: PHASE1
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
NCT06747871 ·Status: RECRUITING ·Phase: NA
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation
NCT00143325 ·Status: COMPLETED ·Phase: PHASE3